##gff-version 3
##sequence-region O15525 1 162
O15525	UniProtKB	Chain	1	162	.	.	.	ID=PRO_0000076500;Note=Transcription factor MafG	
O15525	UniProtKB	Domain	51	114	.	.	.	Note=bZIP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00978	
O15525	UniProtKB	Region	53	76	.	.	.	Note=Basic motif;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00978	
O15525	UniProtKB	Region	79	93	.	.	.	Note=Leucine-zipper;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00978	
O15525	UniProtKB	Modified residue	53	53	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:11154691;Dbxref=PMID:11154691	
O15525	UniProtKB	Modified residue	60	60	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:11154691;Dbxref=PMID:11154691	
O15525	UniProtKB	Modified residue	71	71	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:11154691;Dbxref=PMID:11154691	
O15525	UniProtKB	Modified residue	76	76	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:11154691;Dbxref=PMID:11154691	
O15525	UniProtKB	Modified residue	124	124	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:20068231,PMID:23186163	
O15525	UniProtKB	Cross-link	14	14	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)%3B alternate	
O15525	UniProtKB	Cross-link	14	14	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25114211,ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25114211,PMID:25218447,PMID:25755297,PMID:25772364,PMID:28112733	
O15525	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Abolishes acetylation. Has no effect on binding to NFE2 but impairs the DNA binding and transcriptional activities of NFE2%3B when associated with A-60%3B A-71 and A-76. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11154691;Dbxref=PMID:11154691	
O15525	UniProtKB	Mutagenesis	60	60	.	.	.	Note=Abolishes acetylation. Has no effect on binding to NFE2 but impairs the DNA binding and transcriptional activities of NFE2%3B when associated with A-53%3B A-71 and A-76. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11154691;Dbxref=PMID:11154691	
O15525	UniProtKB	Mutagenesis	71	71	.	.	.	Note=Abolishes acetylation. Has no effect on binding to NFE2 but impairs the DNA binding and transcriptional activities of NFE2%3B when associated with A-53%3B A-60%3B and A-76. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11154691;Dbxref=PMID:11154691	
O15525	UniProtKB	Mutagenesis	76	76	.	.	.	Note=Abolishes acetylation. Has no effect on binding to NFE2 but impairs the DNA binding and transcriptional activities of NFE2%3B when associated with A-53%3B A-60 and A-71. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11154691;Dbxref=PMID:11154691	
